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We studied multiplex IgAN kindreds from Italy (24 kindreds) and the United States (6 kindreds). All were ascertained through biopsy-documented IgAN cases and had at least one more affected member. Relatives provided medical records and were screened for haematuria, proteinuria and renal function. Relatives were classified as affected if they had IgAN on renal biopsy, or, alternatively, haematuria (≥5 red blood cells/high power field) or proteinuria ESRD. The mean age of diagnosis was 33 years and the male:female ratio was 1.5:1. All phenotypes were assigned prospectively before initiation of genotyping. The familial clustering in these pedigrees is consistent with multifactorial determination or autosomal dominant transmission with reduced penetrance. Suggested abnormalities in IgAN have included a maladaptive immune response or altered structure or clearance of IgA (refs 8,9) . Consequent candidate genes include the immunoglobulin genes 9,17 , the major histocompatibility locus 9, 18 , the galactosyl transferases 8, 19 , the IgA Fc receptor 20 (CD89) and uteroglobin 21 . Accordingly, we genotyped polymorphic markers closely linked to these genes. Analysis of the results did not provide evidence of linkage of IgAN to any of these loci under parametric or non-parametric models (Table 1 ). Because gene-targeting studies in mice have raised uteroglobin as a candidate 21 , we also screened the coding sequence of this gene for mutations but identified none. These findings do not implicate any of these candidate loci in familial IgAN. We next carried out a genome-wide analysis of linkage, genotyping polymorphic markers distributed at 10-cM intervals. To test for a locus (Table 2) . Multipoint linkage including all loci typed on chromosome 6 yielded a maximum lod score of 5.6 at D6S1040 with an estimated 60% of kindreds linked ( Fig.  3 and Table 3 ). This lod score exceeds the threshold of 3.28 for significant linkage in the setting of locus heterogeneity and has approximately the same significance as a lod score of 5.3 under models of locus homogeneity 22 . The lod -1 support interval places IGAN1 in the 6.5-cM interval between D6S1702 and D6S262. This evidence for linkage is robust to alternative analyses. The lod score remains greater than or equal to 5.0 for penetrance estimates ranging from 20% to 85% and for phenocopy rates ranging from 0.03 to 0.0001. The lod score remains 5.2 (α=0.59) in analysis of affected members only. Similarly, non-parametric analysis of allele-sharing among affected individuals achieves a non-parametric lod (NPL) score of 5.1 (P=4.8×10 -6 ; Fig. 3 ), which is significant at the genome-wide level 23 . Secondary analysis using a more stringent phenotype, classifying as affected only biopsy-documented cases plus those with either episodic gross haematuria or idiopathic ESRD, continues to provide strong evidence of linkage at IGAN1 (multipoint lod score 5.5, α=0.65). Both Italian (lod score 3.2, α=0.50) and US kindreds (lod score 2.7, α=0.98) contribute and show peak lod scores in the same interval. Locus homogeneity is 1,000-fold less likely than locus heterogeneity, and recessive models of transmission at IGAN1 are rejected.
The other interval with lod score greater than 1.0 lies at 3p23-24; this interval did not reach statistical significance (lod score 2.8, α=0.33; NPL score 2.9, P=0.003), and this result was not altered by multilocus analysis. Re-analysis of genome-wide data in kindreds partitioned into those with positive or negative lod scores at IGAN1 did not yield further loci suggestive of linkage.
These results provide highly significant evidence for linkage of IgAN to 6q22-23 under a dominant model with incomplete penetrance and locus heterogeneity. The observed reduced penetrance is compatible with an inherited susceptibility whose expression is dependent on environmental or genetic modifiers. There are no apparent clinical or demographic features that distinguish families with positive or negative lod scores at IGAN1. IGAN1 lies 80 cM distal to the major histocompatibility locus. Examination of sequence databases indicates that the linked interval does not contain any compelling candidates for IgAN. So far, we have found no evidence of linkage disequilibrium between marker alleles at 6q22-23 and IgAN.
Progress in identification of the IGAN1 gene can proceed on several fronts. Genes identified in this interval can be tested for their role in IgAN and polymorphisms can be used to search for linkage disequilibrium. It is of interest that although IgAN is the most common renal disease among the Zuni native Americans 11 , it is rare in individuals of African ancestry 10 . These observations suggest use of linkage disequilibrium and admixture disequilibrium mapping in IgAN cases in these respective populations 24 . Identification of the molecular defect underlying IGAN1 may provide insight into the pathogenesis, diagnosis and treatment of this cause of renal failure. D6S1043  D6S1056  D6S1021  D6S474  D6S423  D6S979  D6SS712  D6S408  D6S1702  D6S1715  D6S1958  D6S407  D6S1690  D6S1705  D6S1040  AF196xH1  AF162GT1  D6S1572  D6S262  D6S457  D6S1656  D6S472  D6S413  D6S1038  D6S270  D6S1272  D6S1009  G184A08 G165G02 D6S305
Methods
Patients. We ascertained IgAN kindreds through index cases with biopsydocumented disease. Relatives were also examined. Eight Italian kindreds were from the Brescia district of northern Italy and 16 were of diverse geographic origin in Italy. Four kindreds in the US were from Kentucky, one was from Connecticut and one was from Washington State. Eighteen kindreds have been reported 9, [12] [13] [14] [15] [16] ; the relationship of these kindreds to those reported previously is indicated (Table A, Genetic analysis. We prepared genomic DNA from venous blood of kindred members as described 25 . We initially genotyped 384 highly polymorphic markers distributed at intervals of approximately 10 cM using fluorescent primers to direct PCR from genomic DNA followed by fractionation and data collection using an ABI 377 DNA sequencer 25 . Investigators blinded to affection status scored all genotypes using the Genotyper 1.1.1 software. Gene and marker locations were specified according to databases at the National Center of Biotechnology Information, the Whitehead Institute for Genomic research and the Genome Database web sites. We carried out analysis of linkage under parametric and non-parametric models, and pairwise and multipoint parametric analysis using LINK-AGE (ref. 26) v. 5.0 and GENEHUNTER (ref. 27) v. 2.0, respectively. We specified a dominant model of transmission with reduced penetrance (estimated at 75%), allowing for locus heterogeneity with disease allele frequency of 0.001 and phenocopy rate of 0.01 (in secondary analysis using a more stringent phenotype, the phenocopy rate was accordingly reduced to 0.001). NPL scores were calculated using GENEHUNTER. Intervals showing NPL or lod scores >1 in the initial genome-wide analysis as well as several candidate loci were analysed in further detail by typing additional markers. Allele frequencies at marker loci were specified according to their frequency in the families studied; owing to the high marker density, changing the estimates of allele frequencies had little effect on the resulting multipoint lod scores at IGAN1. Likelihood ratios of linkage under models of locus heterogeneity were calculated as LR = αLR (θ 1 ) + (1-α), where θ 1 is the location of the trait locus and α is the proportion of families linked to θ 1 . Multilocus lod scores were calculated as LR = αLR (θ 1 ) + βLR(θ 2 ) + (1-α-β), where β corresponds to the proportion of families linked to θ 2 .
To search for linkage disequilibrium, we compared the frequencies of independent alleles segregating with IGAN1 with those found on independent unlinked chromosomes. Italian and US kindreds were analysed separately using the DISEQIN program 28 .
To search for mutations in the uteroglobin gene, we used primers located in introns to direct amplification of the coding sequences of this gene by PCR (exon 1, F, 5´-GACGGAACCAGAGACGGGCCAGAGCAT-3´, R, 5´-CTGA GACTCAGCATGCCCAG-3´; exon 2, F, 5´-CTTCTCTCCTCTGTGTTGCA -3´, R, 5´-CTTGGGGAAGCCACTTCTAACCAG-3´; exon 3, F, 5´-TCCTCC TAGAGTTGACTGCAC-3´, R, 5´-GTGGACTCAAAGCATGGCAGCGGC -3´; ref. 29) . The products were analysed by single-stranded conformational polymorphism analysis, as described 30 .
